181 related articles for article (PubMed ID: 20089937)
1. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.
Novotny E; Renfroe B; Yardi N; Nordli D; Ness S; Wang S; Weber T; Kurland CL; Yuen E; Eerdekens M; Venkatraman L; Nye JS; Ford L
Neurology; 2010 Mar; 74(9):714-20. PubMed ID: 20089937
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures.
Chung SS; Hogan RE; Blatt I; Lawson P B; Nguyen H; Clark AM; Anders B; Halvorsen MB;
Epilepsy Behav; 2016 Jun; 59():13-20. PubMed ID: 27084978
[TBL] [Abstract][Full Text] [Related]
4. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
Faught E; Wilder BJ; Ramsay RE; Reife RA; Kramer LD; Pledger GW; Karim RM
Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin adjunctive therapy for focal onset seizures in children 1 month to <4 years of age: A double-blind, placebo-controlled, video-electroencephalographic trial.
Mann D; Antinew J; Knapp L; Almas M; Liu J; Scavone J; Yang R; Modequillo M; Makedonska I; Ortiz M; Kyrychenko A; Nordli D; Farkas V; Farkas MK;
Epilepsia; 2020 Apr; 61(4):617-626. PubMed ID: 32189338
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.
Elterman RD; Glauser TA; Wyllie E; Reife R; Wu SC; Pledger G
Neurology; 1999 Apr; 52(7):1338-44. PubMed ID: 10227615
[TBL] [Abstract][Full Text] [Related]
7. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R
Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569
[TBL] [Abstract][Full Text] [Related]
8. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
[TBL] [Abstract][Full Text] [Related]
9. Topiramate as an adjunctive treatment for refractory partial epilepsy in the elderly.
Zhang L; Huang J; Zhuang JH; Huang LQ; Zhao ZX
J Int Med Res; 2011; 39(2):408-15. PubMed ID: 21672344
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy.
Tassinari CA; Michelucci R; Chauvel P; Chodkiewicz J; Shorvon S; Henriksen O; Dam M; Reife R; Pledger G; Karim R
Epilepsia; 1996 Aug; 37(8):763-8. PubMed ID: 8764816
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.
Sharief M; Viteri C; Ben-Menachem E; Weber M; Reife R; Pledger G; Karim R
Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919
[TBL] [Abstract][Full Text] [Related]
12. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
[TBL] [Abstract][Full Text] [Related]
13. Once-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study.
Chung SS; Fakhoury TA; Hogan RE; Nagaraddi VN; Blatt I; Lawson B; Arnold S; Anders B; Clark AM; Laine D; Meadows RS; Halvorsen MB;
Epilepsia; 2014 Jul; 55(7):1077-87. PubMed ID: 24902983
[TBL] [Abstract][Full Text] [Related]
14. Low-dose topiramate in adults with treatment-resistant partial-onset seizures.
Guberman A; Neto W; Gassmann-Mayer C;
Acta Neurol Scand; 2002 Oct; 106(4):183-9. PubMed ID: 12225311
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures.
Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R
Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience.
Faught E
Epilepsia; 1997; 38 Suppl 1():S24-7. PubMed ID: 9092954
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy.
Yen DJ; Yu HY; Guo YC; Chen C; Yiu CH; Su MS
Epilepsia; 2000 Sep; 41(9):1162-6. PubMed ID: 10999555
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of once-daily extended-release topiramate (USL255): a subgroup analysis based on the level of treatment resistance.
Hogan RE; Blatt I; Lawson B; Nagaraddi V; Fakhoury TA; Anders B; Clark AM; Laine D; Halvorsen MB; Chung SS
Epilepsy Behav; 2014 Dec; 41():136-9. PubMed ID: 25461205
[TBL] [Abstract][Full Text] [Related]
20. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC
Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
